Natixis Advisors, L.P. Viatris Inc Transaction History
Natixis Advisors, L.P.
- $54.1 Billion
- Q1 2025
A detailed history of Natixis Advisors, L.P. transactions in Viatris Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 319,196 shares of VTRS stock, worth $2.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
319,196
Previous 335,486
4.86%
Holding current value
$2.7 Million
Previous $4.18 Million
33.46%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$784 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$630 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$549 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$520 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...